Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 0.12% | 283.74 | 1.5% | $847.25m | |
| GILD | Gilead Sciences, Inc. | 0.98% | 86.26 | 1.0% | $795.01m | |
| MRNA | Moderna, Inc. | -0.23% | 176.40 | 0.0% | $769.19m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.01% | 312.98 | 1.9% | $482.01m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.12% | 736.23 | 2.6% | $473.28m | |
| BIIB | Biogen, Inc. | 0.56% | 305.15 | 1.8% | $355.07m | |
| ILMN | Illumina, Inc. | -1.39% | 218.99 | 3.2% | $270.73m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 5.70% | 2.78 | 0.7% | $194.33m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.89% | 96.92 | 4.2% | $161.47m | |
| BNTX | BioNTech SE | -0.88% | 154.85 | 0.0% | $152.12m | |
| MRTX | Mirati Therapeutics, Inc. | 2.89% | 98.62 | 1.6% | $132.21m | |
| TECH | Bio-Techne Corp. | 0.79% | 338.97 | 4.5% | $123.89m | |
| AXSM | Axsome Therapeutics, Inc. | 1.07% | 56.82 | 1.6% | $80.71m | |
| NVAX | Novavax, Inc. | -2.88% | 16.54 | 75.3% | $70.44m | |
| HALO | Halozyme Therapeutics, Inc. | 0.59% | 54.67 | 18.4% | $64.50m |
Company Profile
Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. It produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. The firm's proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.